NCT01316458 2017-06-01
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomy
Novartis
Phase 2 Completed
Clinical Trials
4 trialsNCT00500110 2015-04-28
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00084825 2012-10-26
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00080678 2012-10-12
Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases
M.D. Anderson Cancer Center
Phase 2 Completed